INSP CLASS ACTION DEADLINE: $42.04 Stock Drop at Inspire Medical Systems (INSP) Triggers Securities Fraud Lawsuit Over Concealed Medicare Billing Software Failures & Inspire V Inventory Glut
12/31/2025 01:31 PM • Inspire Medical Systems faces a securities class action lawsuit alleging executives misled investors about operational readiness for the Inspire V device launch. The company allegedly concealed critical failures including delayed Medicare billing software updates and excess inventory of the older Inspire IV device. The stock dropped $42.04 (32.4%) after the company slashed 2025 EPS guidance by over 80%. The Lead Plaintiff deadline is January 5, 2026.
INSP - Company faces securities fraud allegations for concealing operational failures in device launch, resulting in 32.4% stock decline, 80%+ EPS guidance cut, and class action lawsuit with January 5, 2026 deadline for lead plaintiff claims.
Investing.com • Tal Melenboim